Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Sacu: Reduced fluence versus standard photodynamic therapy in combination with intravitreal.... (0.11 sec) 

Reduced fluence versus standard photodynamic therapy in combination with intravitreal …

- duanessolution.com
S Sacu, A Varga, S Michels, G Weigert, K … - British Medical Journal, 2008 - bjo.bmj.com
Results: Baseline characteristics were well balanced in both groups (p>0.05). At
week 12, patients in group A had a mean loss of −3.7 letters compared with a
gain of 3.4 letters in group B (p = 0.04, between both groups). Both ...
Cited by 5 - Related articles - All 5 versions

Photodynamic therapy with verteporfin for short time for chronic central serous …


JL Kim, HW Kim, IH Yoon - J Korean Ophthalmol Soc, 2008 - koreamed.org
PURPOSE: To evaluate the clinical results of short duration photodynamic therapy
(PDT) using verteporfin in patients with chronic central serous
chorioretinopathy (CSC). METHODS: We retrospectively examined 15 eyes after ...
Cited by 2 - Related articles - Cached - All 2 versions

[CITATION] Sapersein. Combination treatment with reduced-fluence photodynamic therapy and …


CN Singh, DA Saperstein - Retina, 2008
Cited by 2 - Related articles

Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, …

- duanessolution.com
CG Kiss, C Simader, S Michels, U Schmidt- … - British Journal of Ophthalmology, 2008 - bjo.bmj.com
Results: Over 9 months, seven patients gained three to 24 letters and one had
unchanged VA. Three patients lost eight to 24 letters due to recurrence and
received another verteporfin treatment at month 6. Median retinal ...
Cited by 4 - Related articles - All 6 versions

Half-Dose Verteporfin Photodynamic Therapy for Acute Central Serous Chorioretinopathy …


WM Chan, TYY Lai, RYK Lai, DTL Liu, DSC … - Ophthalmology, 2008 - Elsevier
OBJECTIVE: To evaluate the efficacy of photodynamic therapy (PDT) with half-dose
verteporfin for treating acute central serous chorioretinopathy (CSC). DESIGN:
Prospective, double-masked, placebo-controlled, randomized clinical trial. ...
Cited by 8 - Related articles - All 4 versions

[CITATION] PROTECT Study Group. Same-day administration of verteporfin and ranibizumab 0.5 mg in …


U Schmidt-Erfurth, S Wolf - Br J Ophthalmol, 2008
Cited by 4 - Related articles

[CITATION] Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab …


FB Aggio, GB Melo, AL Höfling-Lima, FM Eid - Acta Ophthalmologica Scandinavica, 2006 - ncbi.nlm.nih.gov
1: Acta Ophthalmol Scand. 2006 Dec;84(6):831-3. Photodynamic therapy with
verteporfin combined with intravitreal injection of bevacizumab ...
Cited by 9 - Related articles - BL Direct - All 3 versions

Reduced Fluence versus Standard Photodynamic


S Sacu, A Varga, S Michels… - bjo.bmj.com
Page 1. doi: 10.1136/bjo.2008.137885 published online June 27, 2008 Br J
Ophthalmol Stefan Sacu, Alina Varga, Stephan Michels, et al. ...
Related articles

Indikationen für photodynamische Therapie mit Verteporfin im Zeitalter der intravitrealen …


M Stur - Spektrum der Augenheilkunde, 2008 - Springer
Zusammenfassung. Nach Einführung der intravitrealen Therapie ist es zu einem
deutlichen Rückgang der Anwen- dung der photodynamischen Therapie (PDT) mit
Verteporfin gekommen, weil die Resultate nach PDT schlechter sind als nach ...
Related articles

Journal List> J Korean Ophthalmol Soc> v. 50 (9); Sep 2009


JK Chang, SW Kim, JR Oh, K Huh - J Korean Ophthalmol Soc, 2009 - synapse.koreamed.org
The author reviewed the charts of 20 patients (22 eyes) who underwent PDT for
chronic central serous chorioretinopathy. All 22 eyes were treated using an
irradiance of 300 mW over 83 second (25 J/cm 2 ). Postoperative evaluation ...
Related articles - Cached - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google